Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 36325027 approvals

Genesystem Co., Ltd

Official website

Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.

As of 2026-10-10, Genesystem Co., Ltd has 27 Korean MFDS device approvals, 1 PubMed-indexed paper on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Genesystem was established in March 2010 and listed on the KOSDAQ market in May 2021. Its main business is the development, manufacturing, and service of molecular diagnostic solutions, with product lines including molecular diagnostic systems, biochips, test kits, and reaction reagents. Consolidated revenue for 2025 was KRW 381 million, of which 45.52% came from exports, with products supplied through direct and indirect (distributor) sales domestically and abroad as well as OEM supply contracts.

Products & technology

  • Molecular diagnostic systemPoint-of-care molecular diagnostics
  • BiochipReagent-embedded test chip
  • Test kitDiagnostic testing
  • Reaction reagentDiagnostic reagent

Regulatory approvals

data.go.kr

27 Korean MFDS device approvals · 2016–2025

  • MFDSReal-time gene amplificator, nucleic acid2025-07-25
    Product approval · Class 2체외 제인 25-4668 호
  • MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, molecular diagnostics2024-11-13
    Product approval · Class 4체외 제허 24-797 호
  • MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, molecular diagnostics2024-11-13
    Product approval · Class 4체외 제허 24-793 호
  • MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, molecular diagnostics2024-05-08
    Product approval · Class 4체외 제허 24-318 호
  • MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, molecular diagnostics2024-05-08
    Product approval · Class 4체외 제허 24-317 호
  • MFDSExtractor, nucleic acid2023-08-10
    Product approval · Class 1체외 제신 23-1226 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2023-03-31
    Product approval · Class 3체외 제허 23-459 호
  • MFDSIVD reagents for extracting nucleic acids2022-11-07
    Product approval · Class 1체외 제신 22-1549 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-10-14
    Product approval · Class 3체외 제허 22-688 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-09-14
    Product approval · Class 3체외 제허 22-616 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-05-26
    Product approval · Class 3체외 제허 22-342 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-01-26
    Product approval · Class 3체외 제허 22-62 호
Show 15 more
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2022-01-26
    Product approval · Class 3체외 제허 22-61 호
  • MFDSIVD reagents for extracting nucleic acids2021-12-29
    Product approval · Class 1체외 수신 21-2368 호
  • MFDSExtractor, nucleic acid2021-12-22
    Product approval · Class 1체외 수신 21-2310 호
  • MFDSIVD reagents for extracting nucleic acids2021-12-07
    Product approval · Class 1체외 제허 21-987 호
  • MFDSIVD reagents for extracting nucleic acids2021-12-07
    Product approval · Class 1체외 제허 21-986 호
  • MFDSReal-time gene amplificator, nucleic acid2021-10-28
    Product approval · Class 2체외 제인 21-4919 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-07-08
    Product approval · Class 3체외 제허 21-575 호
  • MFDSReal-time gene amplificator, nucleic acid2021-06-04
    Product approval · Class 2체외 제인 21-4480 호
  • MFDSIVD reagents for extracting nucleic acids2021-04-05
    Product approval · Class 1체외 제허 21-255 호
  • MFDSIVD reagents for extracting nucleic acids2021-04-05
    Product approval · Class 1체외 제허 21-254 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-03-25
    Product approval · Class 3체외 제허 21-217 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-04-16
    Product approval · Class 3체외 제허 20-291 호
  • MFDSReal-time gene amplificator, nucleic acid2020-01-30
    Product approval · Class 2체외 제인 20-4072 호
  • MFDSReal-time gene amplificator, nucleic acid2016-10-04
    Product approval · Class 2체외 제인 16-4772 호
  • MFDSTube, blood collecting, sealed, evacuatedRevoked2016-05-24
    Product approval · Class 1체외 제신 16-641 호

R&D and key agreements

Source: DART corporate disclosure

입자기반 다중 PCR 기술(LEM-PIN) 활용 호흡기 4종 진단키트 개발 · 호흡기 질환 · 개발 중 · Developing four respiratory diagnostic test kits using particle-based multiplex PCR (LEM-PIN) technology licensed in from the Korea Institute of Science and Technology (KIST).

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 40 more patents

AI reads

MAA server logs · IP-verified
78
Times AI engines pulled Genesystem Co., Ltd's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

77
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

7
live 0
Last 7 days
55
live 1
Last 30 days
78
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot51
  • GoogleGoogleOther18
  • PerplexityPerplexityBot5
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Genesystem Co., Ltd and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

RollingStone Co., Ltd.5 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

BIONEERCORPORATION5 shared

Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.

GC Medical Science Corporation5 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

SEEGENE, INC.5 shared

Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.

Boditech Med Inc.4 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

Access Bio, Inc.4 shared

Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.

SD BIOSENSOR INC.4 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

GENOLUTION INC.3 shared

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

OSANG HEALTHCARE CO.,LTD.3 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

iNtRON Biotechnology, Inc.3 shared

Founded in 1999 and listed on KOSDAQ in 2011, iNtRON Biotechnology develops bacteriophage-based new drugs via its itLysin and IMPA platforms alongside a molecular diagnostics business.

HLB PANAGENE Co., LTD.3 shared

Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.

CALTH. Inc3 shared

Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition